Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review

被引:253
作者
Puts, M. T. E. [1 ]
Hardt, J. [1 ]
Monette, J. [2 ,3 ]
Girre, V. [4 ]
Springall, E. [5 ]
Alibhai, S. M. H. [6 ,7 ]
机构
[1] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[2] McGill Univ, Jewish Gen Hosp, Div Geriatr Med, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Jewish Gen Hosp, McGill Univ Univ Montreal Solidage Res Grp Frailt, Montreal, PQ H3T 1E2, Canada
[4] Ctr Hosp Dept, Dept Hematol Oncol, La Roche Sur Yon, France
[5] Univ Toronto Lib, Gerstein Sci Informat Ctr, Toronto, ON, Canada
[6] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[7] Univ Hlth Network, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 15期
关键词
ELDERLY CANCER-PATIENTS; CELL LUNG-CANCER; QUALITY-OF-LIFE; BREAST-CANCER; FUNCTIONAL STATUS; PERFORMANCE STATUS; COLORECTAL-CANCER; MULTIDIMENSIONAL EVALUATION; INDEPENDENTLY CONTRIBUTE; COMPREHENSIVE ASSESSMENT;
D O I
10.1093/jnci/djs285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult's medical, psychological, social, and functional capacity. No systematic review of the use of geriatric assessment in oncology has been conducted. The goals of this systematic review were: 1) to provide an overview of all geriatric assessment instruments used in the oncology setting; 2) to examine the feasibility and psychometric properties of those instruments; and 3) to systematically evaluate the effectiveness of geriatric assessment in predicting or modifying outcomes (including the impact on treatment decision making, toxicity of treatment, and mortality). Methods We searched Medline, Embase, Psychinfo, Cinahl, and the Cochrane Library for articles published in English, French, Dutch, or German between January 1, 1996, and November 16, 2010, reporting on cross-sectional, longitudinal, interventional, or observational studies that assessed the feasibility or effectiveness of geriatric assessment instruments. The quality of articles was evaluated using relevant quality assessment frameworks. Results We identified 83 articles that reported on 73 studies. The quality of most studies was poor to moderate. Eleven studies examined psychometric properties or diagnostic accuracy of the geriatric assessment instruments used. The assessment generally took 10-45 min. Geriatric assessment was most often completed to describe a patient's health and functional status. Specific domains of geriatric assessment were associated with treatment toxicity in 6 of 9 studies and with mortality in 8 of 16 studies. Of the four studies that examined the impact of geriatric assessment on the cancer treatment decision, two found that geriatric assessment impacted 40%-50% of treatment decisions. Conclusion Geriatric assessment in the oncology setting is feasible, and some domains are associated with adverse outcomes. However, there is limited evidence that geriatric assessment impacted treatment decision making. Further research examining the effectiveness of geriatric assessment on treatment decisions and outcomes is needed.
引用
收藏
页码:1133 / 1163
页数:31
相关论文
共 116 条
  • [31] Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology
    Droz, Jean-Pierre
    Balducci, Lodovico
    Bolla, Michel
    Emberton, Mark
    Fitzpatrick, John M.
    Joniau, Steven
    Kattan, Michael W.
    Monfardini, Silvio
    Moul, Judd W.
    Naeim, Arash
    van Poppel, Hendrik
    Saad, Fred
    Sternberg, Cora N.
    [J]. BJU INTERNATIONAL, 2010, 106 (04) : 462 - 469
  • [32] Lung cancer in the elderly: performance status and/or geriatric indices?
    Dujon, C.
    Azarian, R.
    Azarian, V.
    Petitpretz, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (04) : 307 - 318
  • [33] Comprehensive geriatric assessment for older adults admitted to hospital
    Ellis, Graham
    Whitehead, Martin A.
    O'Neill, Desmond
    Langhorne, Peter
    Robinson, David
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [34] Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
    Extermann, M
    Aapro, M
    Bernabei, RB
    Cohen, HJ
    Droz, JP
    Lichtman, S
    Mor, V
    Monfardini, S
    Repetto, L
    Sorbye, L
    Topinkova, E
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 55 (03) : 241 - 252
  • [35] A comprehensive geriatric intervention detects multiple problems in older breast cancer patients
    Extermann, M
    Meyer, J
    McGinnis, M
    Crocker, TT
    Corcoran, MB
    Yoder, J
    Haley, WE
    Chen, HB
    Boulware, D
    Balducci, L
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 49 (01) : 69 - 75
  • [36] Are older French patients as willing as older American patients to undertake chemotherapy?
    Extermann, M
    Albrand, G
    Chen, HB
    Zanetta, S
    Schonwetter, R
    Zulian, GB
    Cantor, A
    Droz, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3214 - 3219
  • [37] Comorbidity and functional status are independent in older cancer patients
    Extermann, M
    Overcash, J
    Lyman, GH
    Parr, J
    Balducci, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1582 - 1587
  • [38] Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit
    Flood, Kellie L.
    Carroll, Maria B.
    Le, Cyndi V.
    Ball, Linda
    Esker, Debbie A.
    Carr, David B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2298 - 2303
  • [39] Fratino Lucia, 1999, Rays (Rome), V24, P53
  • [40] Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study
    Freyer, G
    Geay, JF
    Touzet, S
    Provencal, J
    Weber, B
    Jacquin, JP
    Ganem, G
    Tubiana-Mathieu, N
    Gisserot, O
    Pujade-Lauraine, E
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (11) : 1795 - 1800